ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $149,000 | +27.4% | 36,284 | +10.8% | 0.00% | – |
| Q4 2021 | $117,000 | +30.0% | 32,749 | +50.2% | 0.00% | – |
| Q1 2021 | $90,000 | +73.1% | 21,799 | +66.3% | 0.00% | – |
| Q4 2020 | $52,000 | -16.1% | 13,105 | -42.5% | 0.00% | – |
| Q2 2020 | $62,000 | -82.9% | 22,801 | -79.3% | 0.00% | -100.0% |
| Q2 2019 | $362,000 | +583.0% | 110,029 | +314.1% | 0.00% | – |
| Q4 2017 | $53,000 | +178.9% | 26,569 | +136.1% | 0.00% | – |
| Q3 2016 | $19,000 | -85.7% | 11,254 | -91.1% | 0.00% | -100.0% |
| Q2 2016 | $133,000 | +329.0% | 126,474 | +755.1% | 0.00% | – |
| Q2 2015 | $31,000 | -68.4% | 14,791 | -72.4% | 0.00% | -100.0% |
| Q3 2014 | $98,000 | – | 53,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |